Synergistic effect of insulin-like growth factor-i and...

Details Synergistic effect of insulin-like growth factor-i and... Synergistic effect of insulin-like growth factor-i and...

A - Human Necessities

61

K

A61K 38/30 (2006.01)

Patent

CA 2146581

Erythropoietin (EPO) and insulin-like growth factor (IGF); pharmaceutical compositions thereof and therapeutic and prophylactic methods to increase the hematocrit are disclosed herein. increase in hematocrit and reticulocyte count is observed by IGF-I treatment alone or in combination with an other cytokine or growth factor. Also disclosed is the synergistic effect of EPO and IGF-I on hematocrit and reticulocyte count, and the use thereof for treating disease associated with a low erythropoietin level.

Affiliated with

Also associated with

Rating

Synergistic effect of insulin-like growth factor-i and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synergistic effect of insulin-like growth factor-i and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic effect of insulin-like growth factor-i and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1895287